Antisense oligonucleotide eluforsen is safe and improves respiratory symptoms in F508DEL cystic fibrosis.
Eluforsen: a potential new treatment option for people with cystic fibrosis (CF) due to the F508del gene mutation?
Rationalizing endpoints for prospective studies of pulmonary exacerbation treatment response in cystic fibrosis
Impact of azithromycin on the clinical and antimicrobial effectiveness of tobramycin in the treatment of cystic fibrosis
Comparison of two pancreatic enzyme products for exocrine insufficiency in patients with cystic fibrosis
